http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113425679-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c27f4a786895417d03d0b1045587100
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02
filingDate 2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b758feb73cb8746a65f5d4f377f3d55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23af9e4949c66b7b788c08fe053900c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_153288303d59c651e2022ceeb1b5a9c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf719accd8ff5d570a6defec1c742277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d700cf84eeef24701aae2aae4404db3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6171f2f73c38aa3e0923a52e14990aab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e7d574d11670611324b845e16b21593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5e1ce26104a122c7ed277bf8380ec33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55513b9d913f30ae2feee8295d1397c2
publicationDate 2021-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113425679-A
titleOfInvention Nitazoxanide injection and preparation method and application thereof
abstract The invention provides a nitazoxanide injection preparation and a preparation method and application thereof. Overcomes the defects of low bioavailability of the tablet and the suspension, inconvenient administration of part of animals and the like; can reduce the dosage, is convenient to use, has the functions of resisting animal parasites such as protozoa and nematodes, and provides a new dosage form for clinical medication.
priorityDate 2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414359002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2331

Total number of triples: 36.